Annual emergency department visits for skin and soft tissue infections (SSTI) are on the rise nationwide, and an increased incidence of abscesses is the likely culprit. MRSA is quickly emerging as the most common cause of purulent SSTIs, and Trimethoprim-Sulfamethoxazole (TMP-SMX) remains a cost-effective first line enteral antimicrobial to treat it. The primary treatment for a cutaneous abscess is incision and drainage (I&D),
Read More